← FDA Drug Approvals (Drugs@FDA)

JOENJA

NDA · New Drug Application · Sponsor: PHARMING · Approved 2023-03-24

Drug application

FDA Application #

NDA217759

Application type

New Drug Application

Brand name

JOENJA

Generic name

LENIOLISIB

Active ingredients

LENIOLISIB PHOSPHATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

PHARMING

Manufacturer

Pharming Healthcare Inc.

First approval

2023-03-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown